Investor Update

Basel, 16 July 2020

Reminder: Invitation to Roche’s Half Year Results 2020 Live Video Webcast and Conference Call

Roche will publish its Half Year Results of 2020 prior to the opening of the Swiss Stock Exchange on Thursday, 23rd July 2020 .


07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)


Release will be e-mailed and posted on the Roche IR website click here
Presentation slides will be posted on the Roche IR website click here


We would like to invite all interested parties to watch the live video webcast.
13:00 - 14:30 CEST / 12:00 - 13:30 BST
07:00 - 08:30 AM EDT / 04:00 - 05:30 AM PDT


Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers).


  • Severin Schwan, CEO Roche Group
  • Bill Anderson, CEO Roche Pharmaceuticals
  • Thomas Schinecker, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer

Access to live video webcast on 23 July 2020 (no pre-registration required)
Please access by clicking on


Access to Conference Call (pre-registration is only required in case you want to participate via phone and not via live video webcast)
You will receive phone numbers, passcode and your personal PIN to direct access the conference call by pre-registering here.


A replay of the live video webcast will be available following the event on the Roche Investor Relations website.


Best regards,

Karl Mahler
Head of Investor Relations and Roche Group Planning

Roche Investor Relations
Dr. Karl Mahler
Phone: +41 61 68-78503
Jon Kaspar Bayard
Phone: +41 61 68-83894
Dr. Sabine Borngräber
Phone: +41 61 68-88027
Dr. Bruno Eschli
Phone: +41 61 68-75284
Dr. Birgit Masjost
Phone: +41 61 68-84814
Dr. Gerard Tobin
Phone: +41 61 68-72942
Investor Relations North America
Loren Kalm
Phone: +1 650 225 3217
Dr. Lisa Tuomi
Phone: +1 650 467 8737